Superficial thrombophlebitis in a patient with COVID 19: Heparin treatment after evaluation of D-Dimer

Dermatol Ther. 2020 Jul;33(4):e13768. doi: 10.1111/dth.13768. Epub 2020 Jul 3.

Authors

Abdullah Demirbaş¹, Ömer F Elmas², Ümit Türsen³, Mustafa Atasoy⁴, Torello Lotti⁵

Affiliations

¹ Department of Dermatology, Konya Numune Hospital, Konya, Turkey.
² Department of Dermatology, Kırşehir Ahi Evran University, Kırşehir, Turkey.
³ Department of Dermatology, Mersin University, Mersin, Turkey.
⁴ Department of Dermatology, Health Science University, Kayseri City Hospital, Kayseri, Turkey.
⁵ Department of Dermatology, Guglielmo Marconi University, Rome, Italy.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adolescent
Anticoagulants / therapeutic use
Betacoronavirus*
Biomarkers / blood
COVID-19
Coronavirus Infections / complications*
Coronavirus Infections / epidemiology
Fibrin Fibrinogen Degradation Products / metabolism*
Heparin / therapeutic use*
Humans
Male
Middle Aged
Pandemics
Pneumonia, Viral / complications*
Pneumonia, Viral / epidemiology
SARS-CoV-2
Thrombophlebitis / blood
Thrombophlebitis / drug therapy*
Thrombophlebitis / etiology

Substances

Anticoagulants
Biomarkers
Fibrin Fibrinogen Degradation Products
fibrin fragment D
Heparin